Should patients with diabetes have a thyroid‑stimulating hormone (TSH) test ordered?

Yes, diabetes—specifically type 1 diabetes—is a clear indication for ordering TSH levels.

Patients with type 1 diabetes should have TSH measured at diagnosis (when clinically stable) and then screened periodically every 1-2 years, as type 1 diabetes is a recognized risk factor for thyroid dysfunction. 1, 2, 3

The Evidence-Based Rationale

Type 1 Diabetes: Strong Indication for TSH Screening

The American Diabetes Association guidelines consistently recommend TSH screening in type 1 diabetes patients because:

• Autoimmune thyroid disease occurs in 17-30% of individuals with type 1 diabetes—making it the most common autoimmune disorder associated with diabetes 1, 2, 3
• At diagnosis, 25% of children with type 1 diabetes already have thyroid autoantibodies, which predict future thyroid dysfunction 1
• Type 1 diabetes is explicitly listed as a risk factor for elevated TSH by the U.S. Preventive Services Task Force 4

Specific screening protocol for type 1 diabetes:

1. Measure TSH at diagnosis when clinically stable (avoid during DKA due to "euthyroid sick syndrome") 1, 2
2. If normal, recheck every 1-2 years 2, 3
3. Screen sooner if symptoms develop, thyromegaly appears, growth rate is abnormal, or unexplained glycemic variability occurs 2, 3
4. Consider checking thyroid antibodies (anti-TPO, anti-thyroglobulin) soon after diagnosis 2, 3

Type 2 Diabetes: Weaker but Reasonable Indication

For type 2 diabetes, the evidence is less compelling:

• The USPSTF does not list type 2 diabetes as a specific risk factor for thyroid dysfunction 4
• Research shows the incidence of thyroid dysfunction in type 2 diabetics may not be higher than healthy controls after adjusting for confounding variables 5
• However, aggressive case-finding is reasonable in high-risk groups, which could include type 2 diabetes patients with other risk factors (female sex, advancing age, family history, autoimmune disease) 6

Clinical Implications That Matter

Why This Screening Matters for Outcomes

Untreated thyroid dysfunction in diabetic patients directly impacts morbidity:

• Subclinical hypothyroidism increases risk of symptomatic hypoglycemia and reduces linear growth rate in children 1, 2, 1
• Hyperthyroidism causes deterioration of glycemic control and increases cardiovascular risk 1, 7
• Hypothyroidism causes insulin resistance but also reduces hepatic glucose production, potentially increasing hypoglycemia risk in patients on glucose-lowering drugs 7
• Some evidence suggests TSH levels correlate with diabetic retinopathy and renal failure risk, independent of glycemic control 8, 9

Common Pitfalls to Avoid

1. Don't check TSH during diabetic ketoacidosis or acute hyperglycemia—you'll get misleading results from "euthyroid sick syndrome." Wait until metabolic stability is achieved 1, 2, 3

2. Don't ignore borderline TSH elevations in poorly controlled diabetes—uncontrolled diabetes can transiently elevate TSH, which may normalize with improved glycemic control 7

3. Be aware of metformin's effect—patients on metformin may have slightly lower TSH levels than those not on metformin 10

Bottom Line Algorithm

For Type 1 Diabetes:

• ✓ Order TSH at diagnosis (when stable)
• ✓ Repeat every 1-2 years routinely
• ✓ Consider thyroid antibodies at diagnosis
• ✓ Screen sooner if symptoms, growth issues, or glycemic variability

For Type 2 Diabetes:

• Consider TSH if patient has additional risk factors: female, age >60, family history of thyroid disease, personal history of autoimmune disease, or atrial fibrillation 6
• Otherwise, case-by-case clinical judgment

The distinction matters: type 1 diabetes warrants routine screening due to the autoimmune link, while type 2 diabetes alone is not sufficient justification without additional risk factors.